Name: Antipeptic Ulcer Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH3509
Price: 4350 USD
Availability: InStock

Antipeptic Ulcer Drugs Market Size Share Growth And Forecast 2023-2030

Antipeptic Ulcer Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Antipeptic Ulcer Drugs Market is segmented By Product&nbsp;(Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs), By Application&nbsp;(Duodenal Ulcers, Gastritis, Gastric Ulcers, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel&nbsp;(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region&nbsp;(North America, Europe, South America, Asia Pacific, Middle East,&nbsp;and Africa)&ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

<blockquote>
Antipeptic Ulcer Drugs Market is estimated to reach&nbsp;at a CAGR of 4% during the forecast period (2022-2029).&nbsp;&nbsp;
</blockquote>

Antipeptic Ulcer Drugs Market&nbsp;-&nbsp;Strategic Insights

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>4%</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Product,&nbsp;By Application, By Distribution Channel,&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

To Get a Free Sample <a href="https://www.datamintelligence.com/download-sample/antipeptic-ulcer-drugs-market">Click here</a>

Antiulcer agents and medications for acid peptic disease are commonly used drugs that rarely cause liver injury. Both classes of antiulcer medications block the pathways of acid production or secretion, decreasing gastric acidity, improving symptoms and aiding in healing of acid-peptic diseases.

<h3>Market Dynamics:</h3>

The anti-peptic ulcer drug market growth is driven by the rising prevalence of peptic ulcers, growing R&amp;D activities due to government support and policies and increasing adoption of triple therapy. Moreover, the rising preference of patients to consume drugs instead of surgical procedures is driving the market growth in the forecast period.

Rising prevalence of peptic ulcer, is expected to drive the growth in the forecast period

A peptic ulcer is one of the serious medical problems. According to Harvard Health Publishing, every year, peptic ulcers affect more than 4 million people in the U.S. Additionally, it occurs irrespective of the age bracket, and it is estimated that 1 in 10 individuals are likely to develop this disease at some point in their life. The increasing prevalence of peptic ulcer disease drives the demand for effective anti-peptic ulcer drugs across the globe.

Growing R&amp;D activities and strong pipeline of new drugs, is expected to drive the growth in the forecast period

The rising prevalence of peptic ulcer disease globally propels the key industry players to invest in R&amp;D activities. This results in the new drug launches for the treatment of peptic ulcer disease, which has a positive impact on market growth. For instance, in November 2019, RedHill Biopharma Ltd. received USFDA approval for RHB-105 (Talicia) to treat Helicobacter pylori in adults.

The conduction of clinical trials for new drugs to overcome the complications related to the currently available drugs is another factor likely to fuel the market growth during the forecast period. For instance, according to clinicaltrials.gov, Takeda Pharmaceuticals has a drug Vonoprazan fumarate in Phase 3 trials, the drug of category potassium-competitive acid blockers (P-CABs) for peptic ulcer disease treatment.

Side effects associated with peptic ulcer drugs is likely to hamper the market growth

Side effects associated with proton pump inhibitors like nutritional deficiency (magnesium, Vit B12), increased risk of gastroenteritis, bowel upset, diarrhea, gastric ulcers and duodenal ulcers, and side-effects associated with anticholinergic drugs include urine retention, dry mouth, and constipation may restrict the market growth.

<h3>COVID-19 Impact Analysis:</h3>

The COVID-19 pandemic has led to the halt of several industrial processes causing unprecedented economic loss. However, pharmaceutical companies are thriving in these difficult times owing to the increasing demand for medication drugs across the globe. Likewise, the demand for these ulcer drugs is experiencing considerable growth as major pharmaceutical companies focus on R&amp;D activities to develop new drugs and cater to the demand for OTC drugs across several stores. The market is, therefore, expected to showcase positive growth during the forecast period.

<h3>Segment Analysis:</h3>

The proton-pump inhibitor segment is expected to hold largest share in this market segment

Treatment of peptic ulcers in Helicobacter pylori-positive patients should include antimicrobial therapy to eradicate the infection; based on considerations of primary antimicrobial resistance and safety, one recommended regimen is the combination of a proton-pump inhibitor. They do so by irreversibly inhibiting the stomach&#39;s H⁺/K⁺ ATPase proton pump. They also have true efficacy and cost-effectiveness in preventing NSAID-associated ulcer complications, such as bleeding and perforation.

The duodenal ulcers segment is expected to hold largest share in this market segment

The growing prevalence of duodenal ulcers and the rising awareness about therapeutic launches for its treatment are some of the factors attributable to its dominance during the forecast period. For instance, in July 2019, ANI Pharmaceuticals, in partnership with Appco Pharma, announced the launch of generic ranitidine capsules to treat duodenal ulcers.

The retail pharmacies segment is expected to hold largest share in this market segment

The retail Pharmacies segment is expected to dominate during the forecast period. Peptic ulcer medications are easily, readily available in retail pharmacies as the generic medicine. Retail pharmacies offer convenient services, including home delivery of medicines and availability of all types of drugs and medicines. Moreover, consumer preference for easy availability of products due to busy lifestyles and hectic work schedules is anticipated to boost antipeptic ulcer drugs market growth.

<h3>Geographical Analysis:</h3>

North America region holds the largest market share of global antipeptic ulcer drugs market 

North America region is expected to hold a dominant position in the global anti-peptic ulcer drugs market over the forecast period, owing to increasing research and development activities, increasing incidence of peptic ulcers in the U.S. that drives the demand for peptic ulcer drugs in the region. For instance, according to Harvard Health Publishing, peptic ulcers affect more than 4 million people in the U.S every year. For instance, in May 2020, researchers from the Michael E. De-Bakey veterans&rsquo; affairs medical center received FDA approval for the three-drug combination of omeprazole, amoxicillin, and rifabutin in one capsule RHB-105, which effectively eradicates helicobacter pylori infection in adults.

<h3>Competitive Landscape:</h3>

The global antipeptic ulcer drugs market is highly competitive with presence of global companies.&nbsp; Some of the key players which are contributing to the growth of the market include Eisai Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., HeliCure AB, AstraZeneca PLC, Ore Pharmaceuticals, Inc, Zydus Cadila, Abbott Laboratories, Pfizer, GlaxoSmithKline, Sihuan Pharmaceutical, Huadong Medicine, Xian Janssen pharmaceutical, Yangtze River pharmaceutical, Changzhou siyao pharmaceuticals. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in July 2019, Zydus Cadila received USFDA approval for Misoprostol tablets for stomach ulcers.

Antipeptic Ulcer Drugs Market Key Companies to Watch

AstraZeneca PLC

Overview: AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It is perhaps best known for its involvement in developing the Oxford-Astrazeneca COVID-19 vaccine.

Product Portfolio: The Company&rsquo;s portfolio comprised of oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Key Developments: In April 2018, AstraZeneca in partnership with Daiichi Sankyo launched Nexium 10mg and 20mg granules for suspension, a proton pump inhibitor for the peptic ulcer treatment.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Frequently Asked Questions</h3>

What is the Projected CAGR value of the Antipeptic Ulcer Drugs Market?

Antipeptic Ulcer Drugs Market is expected to grow at a High CAGR 4% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America&nbsp;region Controls&nbsp;the&nbsp;Antipeptic Ulcer Drugs Market&nbsp;during 2022-2029

Explain Some of the key players in the Antipeptic Ulcer Drugs Market?

Eisai Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., HeliCure AB, AstraZeneca PLC, Ore Pharmaceuticals, Inc, Zydus Cadila, Abbott Laboratories, Pfizer, GlaxoSmithKline, Sihuan Pharmaceutical, Huadong Medicine, Xian Janssen pharmaceutical, Yangtze River pharmaceutical, Changzhou siyao pharmaceuticals.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/pet-food-market">Pet Food Market</a>

<a href="https://www.datamintelligence.com/research-report/organic-pet-food-market">Organic Pet Food Market</a>

<a href="https://www.datamintelligence.com/research-report/freeze-dried-pet-food-market">Freeze-Dried Pet Food Market</a>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by Product</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Application</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising prevalence of peptic ulcer</li>
				<li>Growing R&amp;D activities and strong pipeline of new drugs</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Side effects associated with peptic ulcer drugs</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>PEST Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>&nbsp;Proton Pump Inhibitors (PPIs)*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Potassium-Competitive Acid Blockers (P-CAB)</li>
		<li>Antacids</li>
		<li>H2 Antagonists</li>
		<li>Ulcer Protective Drugs</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment</li>
			<li>Market Attractiveness Index, By Application Segment</li>
		</ol>
		</li>
		<li>&nbsp;Duodenal Ulcers*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>&nbsp;Gastritis</li>
		<li>Gastric Ulcers</li>
		<li>Gastroesophageal Reflux Disease (GERD)</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel Segment</li>
			<li>Market Attractiveness Index, By Distribution channel Segment</li>
		</ol>
		</li>
		<li>&nbsp;Retail Pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Hospital Pharmacies</li>
		<li>Online Pharmacies</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>Key Companies to Watch</li>
		<li>Company with disruptive technology</li>
		<li>Start Up Companies</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>AstraZeneca PLC*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Eisai Co., Ltd</li>
		<li>Daewoong Pharmaceutical Co., Ltd</li>
		<li>Takeda Pharmaceutical Company Limited</li>
		<li>HeliCure AB</li>
		<li>Ore Pharmaceuticals, Inc</li>
		<li>Zydus Cadila</li>
		<li>Abbott Laboratories</li>
		<li>Pfizer</li>
		<li>GlaxoSmithKline</li>
		<li>Sihuan Pharmaceutical</li>
		<li>Huadong Medicine</li>
		<li>Xian Janssen pharmaceutical</li>
		<li>Yangtze River pharmaceutical</li>
		<li>Changzhou siyao pharmaceuticals(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence&nbsp;&nbsp;</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 1 Global Antipeptic Ulcer Drugs Market Value, By Product, 2021,2025 &amp; 2029($ Million)

Table 2 Global Antipeptic Ulcer Drugs Market Value, By Application, 2021,2025 &amp; 2029($ Million)

Table 3 Global Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2021,2025 &amp; 2029($ Million)

Table 4 Global Antipeptic Ulcer Drugs Market Value, By Region, 2021,2025 &amp; 2029($ Million)

Table 5 Global Antipeptic Ulcer Drugs Market Value, By Product, 2021,2025 &amp; 2029($ Million)

Table 6 Global Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 7 Global Antipeptic Ulcer Drugs Market Value, By Application, 2021,2025 &amp; 2029($ Million)

Table 8&nbsp;&nbsp;&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 9 Global Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2021,2025 &amp; 2029($ Million)

Table 10&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 11&nbsp;&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Value, By Region, 2021,2025 &amp; 2029($ Million)

Table 12&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Value, By Region, 2018-2029($ Million)

Table 13&nbsp;&nbsp; North America Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 14&nbsp;&nbsp; North America Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 15&nbsp;&nbsp; North America Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 16&nbsp;&nbsp; North America Antipeptic Ulcer Drugs Market Value, By Country, 2018-2029($ Million)

Table 17&nbsp;&nbsp;&nbsp; South America Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 18&nbsp;&nbsp; South America Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 19&nbsp;&nbsp; South America Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 20&nbsp;&nbsp; South America Antipeptic Ulcer Drugs Market Value, By Country, 2018-2029($ Million)

Table 21&nbsp;&nbsp; Europe Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 22&nbsp;&nbsp; Europe Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 23&nbsp;&nbsp; Europe Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 24&nbsp;&nbsp; Europe Antipeptic Ulcer Drugs Market Value, By Country, 2018-2029($ Million)

Table 25&nbsp;&nbsp; Asia-Pacific Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 26&nbsp;&nbsp; Asia-Pacific Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 27&nbsp;&nbsp; Asia-Pacific Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 28&nbsp;&nbsp; Asia-Pacific Antipeptic Ulcer Drugs Market Value, By Country, 2018-2029($ Million)

Table 29&nbsp;&nbsp; Middle East &amp; Africa Antipeptic Ulcer Drugs Market Value, By Product, 2018-2029($ Million)

Table 30&nbsp;&nbsp; Middle East &amp; Africa Antipeptic Ulcer Drugs Market Value, By Application, 2018-2029($ Million)

Table 31&nbsp;&nbsp; Middle East &amp; Africa Antipeptic Ulcer Drugs Market Value, By Distribution Channel, 2018-2029($ Million)

Table 32&nbsp;&nbsp; AstraZeneca PLC: Overview

Table 33&nbsp;&nbsp; AstraZeneca PLC: Product Portfolio

Table 34&nbsp;&nbsp; AstraZeneca PLC: Key Developments

Table 35&nbsp;&nbsp; Eisai Co., Ltd: Overview

Table 36&nbsp;&nbsp; Eisai Co., Ltd: Product Portfolio

Table 37&nbsp;&nbsp; Eisai Co., Ltd: Key Developments

Table 38&nbsp;&nbsp; Daewoong Pharmaceutical Co., Ltd: Overview

Table 39&nbsp;&nbsp; Daewoong Pharmaceutical Co., Ltd: Product Portfolio

Table 40&nbsp;&nbsp; Daewoong Pharmaceutical Co., Ltd: Key Developments

Table 41&nbsp;&nbsp; Takeda Pharmaceutical Company Limited: Overview

Table 42&nbsp;&nbsp; Takeda Pharmaceutical Company Limited: Product Portfolio

Table 43&nbsp;&nbsp; Takeda Pharmaceutical Company Limited: Key Developments

Table 44&nbsp;&nbsp; HeliCure AB: Overview

Table 45&nbsp;&nbsp; HeliCure AB: Product Portfolio

Table 46&nbsp;&nbsp; HeliCure AB: Key Developments

Table 47&nbsp;&nbsp; Ore Pharmaceuticals, Inc: Overview

Table 48&nbsp;&nbsp; Ore Pharmaceuticals, Inc: Product Portfolio

Table 49&nbsp;&nbsp; Ore Pharmaceuticals, Inc: Key Developments

Table 50&nbsp;&nbsp; Zydus Cadila: Overview

Table 51&nbsp;&nbsp; Zydus Cadila: Product Portfolio

Table 52&nbsp;&nbsp; Zydus Cadila: Key Developments

Table 53&nbsp;&nbsp; Abbott Laboratories: Overview

Table 54&nbsp;&nbsp; Abbott Laboratories: Product Portfolio

Table 55&nbsp;&nbsp; Abbott Laboratories: Key Developments

Table 56&nbsp;&nbsp; Pfizer: Overview

Table 57&nbsp;&nbsp; Pfizer: Product Portfolio

Table 58&nbsp;&nbsp; Pfizer: Key Developments

Table 59&nbsp;&nbsp; GlaxoSmithKline: Overview

Table 60&nbsp;&nbsp; GlaxoSmithKline: Product Portfolio

Table 61&nbsp;&nbsp; GlaxoSmithKline: Key Developments

List of Figures

Figure 1&nbsp;&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 2&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 3&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 4&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Share, By Region, 2021 &amp; 2029(%)

Figure 5&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 6&nbsp;&nbsp; Global Antipeptic Ulcer Drugs Market Y-o-Y Growth, By Product, 2021 &amp; 2029(%)

Figure 7&nbsp;&nbsp;&nbsp; Proton Pump Inhibitors (PPIs): Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 8&nbsp;&nbsp; Potassium-Competitive Acid Blockers (P-CAB): Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 9&nbsp;&nbsp; Antacids: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 10 H2 Antagonists: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 11&nbsp; Ulcer Protective Drugs: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 12 Global Antipeptic Ulcer Drugs Market Y-o-Y Growth, By Application, 2021 &amp; 2029(%)

Figure 13 Gastritis: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 14 Duodenal Ulcers: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 15 Gastroesophageal Reflux Disease (GERD): Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 16 Gastric Ulcers: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 17&nbsp; Global Antipeptic Ulcer Drugs Market Y-o-Y Growth, By Distribution Channel, 2021 &amp; 2029(%)

Figure 18 Hospital Pharmacies: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 19 Retail Pharmacies: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 20 Online Pharmacies: Global Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 21 Global Antipeptic Ulcer Drugs Market Y-o-Y Growth, By Region, 2021 &amp; 2029(%)

Figure 22 North America Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 23 North America Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 24 North America Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 25 North America Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 26 North America Antipeptic Ulcer Drugs Market Share, By Country, 2021 &amp; 2029(%)

Figure 27 South America Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 28 South America Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 29 South America Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 30 South America Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 31 South America Antipeptic Ulcer Drugs Market Share, By Country, 2021 &amp; 2029(%)

Figure 32 Europe Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 33 Europe Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 34 Europe Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 35 Europe Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 36 Europe Antipeptic Ulcer Drugs Market Share, By Country, 2021 &amp; 2029(%)

Figure 37 Asia-Pacific Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 38 Asia-Pacific Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 39 Asia-Pacific Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 40 Asia-Pacific Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 41 Asia-Pacific Antipeptic Ulcer Drugs Market Share, By Country, 2021 &amp; 2029(%)

Figure 42 Middle East &amp; Africa Antipeptic Ulcer Drugs Market Value, 2018-2029($ Million)

Figure 43 Middle East &amp; Africa Antipeptic Ulcer Drugs Market Share, By Product, 2021 &amp; 2029(%)

Figure 44 Middle East &amp; Africa Antipeptic Ulcer Drugs Market Share, By Application, 2021 &amp; 2029(%)

Figure 45 Middle East &amp; Africa Antipeptic Ulcer Drugs Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 46 AstraZeneca PLC: Financials

Figure 47 Eisai Co., Ltd: Financials

Figure 48 Daewoong Pharmaceutical Co., Ltd: Financials

Figure 49 Takeda Pharmaceutical Company Limited: Financials

Figure 50 HeliCure AB: Financials

Figure 51 Ore Pharmaceuticals, Inc: Financials

Figure 52 Zydus Cadila: Financials

Figure 53 Abbott Laboratories: Financials

Figure 54 Pfizer: Financials

Figure 55 GlaxoSmithKline: Financials